Iman Zarei ([email protected])
I completed my PhD in Human Nutrition, minor in Molecular Biology & Biotechnology at the University of the Philippines joined with Colorado State University, USA. My PhD research focused on identification of dietary biomarkers in cereal bran using metabolomics from two human intervention studies in adults and children and determination of cereal bran property in inhibiting bacterial pathogenicity in mouse cell line. As my cognate was Molecular Biology & Biotechnology, during my PhD program, I also worked over three years as lar at the Grain Quality and Nutrition Center as well as the Genetic Transformation Laboratory of the International Rice Research Institute (IRRI) in the Philippines, the most renowned rice research organization in the world. My work at IRRI included rice metabolomics, identification rice varieties with high protein content, and genetic modifications of rice for vitamin A (Golder Rice project) and iron and zinc bio-fortification. I currently work within the LongITools project (https://longitools.org) to study the effects physical activity and diet exposures on human health in determining the risks of chronic cardiovascular and metabolic diseases.
Janne Jänis ([email protected])
Education: High school graduate 1993 (Talvisalo High School, Savonlinna); M.Sc. 1999, Ph.Lic. 2003, Ph.D. 2005 (University of Joensuu); Docent, mass spectrometry 2008- (University of Helsinki, Faculty of Pharmacy).
Academic career: Research assistant 1998-1999, Early-stage researcher/PhD student 1999-2005 (University of Joensuu); Visiting researcher 2002 (University of Warwick, UK); Postdoctoral researcher 2005-2008, Assistant professor 2008-2009 (University of Joensuu); Professor 2010-current (University of Eastern Finland).
Research interests: High-resolution mass spectrometry, bioanalytical chemistry, structural proteomics, metabolomics, petroleomics, biorefining/thermochemical conversion, enzyme catalysis, environmental chemistry. If interested in collaboration (or contract research) with us, please send me an email.
Johnson Lok ([email protected])
Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease (BestTreat) is a program funded by the European Commission which aims to develop novel diagnostic and therapeutic methods for NAFLD based on gut microbiota.
Aim of my study is to investigate the association between the NAFLD progression and alterations in gut microbiota and metabolites. Correlations between metagenomics, metabolomics, imaging data and other prognostic biomarkers for NAFLD are investigated to elucidate the mechanisms behind metabolic benefits conveyed by specific functional strains of the gut microbiota to the pathophysiology and pathogenesis of NAFLD. Metagenomic and metabolomic signatures of specific gut microbiota and metabolites will be used to develop novel microbiome-based disease prognostic biomarkers and therapeutic interventions for NAFLD.
LC-MS metabolomics center
Lilian Fernandes Silva ([email protected])
I am a Researcher in Precision Medicine at the Internal Medicine Department at the University of Eastern Finland and a fellow at the David Geffen School of Medicine, UCLA. My research focuses on identifying and characterizing metabolites involved in metabolic diseases, particularly on understanding metabolic pathways across different physiological states, including normal glucose tolerance, pre-diabetes, and type 2 diabetes, by leveraging advanced metabolomics and clinical data, aiming to develop personalized approaches for the early detection and treatment of metabolic disorders, contributing to the advancement of precision medicine in metabolic diseases. With a strong background in pharmacy, I combine Biochemical expertise with clinical Insights to translate findings into potential Therapeutic interventions.
Olli Kärkkäinen ([email protected])
I study the effects of different exposures, e.g. alcohol and drugs, to the metabolic processes in the body using metabolomics methods. My coal is to increase our understanding of disease processes to identify novel biomarkers of exposure and to identify new targets for treatment.
Retu Haikonen ([email protected])
Current research projects revolves around betainized compounds. In order to reveal metabolic role of the compounds related to diet, health and gut various modern omic techniques are used. For example metabolomics and transcriptomics are utilized to clarify bioactivity of these novel compounds. The ultimate goal is better health and well-being.
Sami Myllymaa ([email protected])
Adjunct professor Sami Myllymaa received his Ph.D. degree in 2010 and the title of docent in the field of Medical Physics, especially biomaterials and bioelectrode technology in 2014 from the University of Eastern Finland. He is currently acting as a Senior Researcher and Co-head of the Sleep Technology and Analytics Group (STAG) at the Department of Applied Physics, University of Eastern Finland.
His current research is focused on development of novel wearable sensors and machine learning solutions for personalized diagnostics and prognostics of sleep disorders (obstructive sleep apnoea, sleep bruxism). Furthermore, he has been very active in the field of salivary metabolomics and development of new coatings and electrochemical biosensors for point-of-care diagnostics. In addition to scientific publications, his work has led to commercialization of the scientific innovations. He involved to the development of an EEG electrode set for emergency medicine. This BrainStatus EEG-electrode set (Bittium Corp.) is patented, CE-approved and currently marketed globally (https://www.bittium.com/products_services/medical/bittium_brainstatus).